PRODUCT DETAILS

About Gibtulio Met 12.5mg/500mg Tablet

EMPAGLIFLOZIN+METFORMIN is a combination drug that belongs to the anti-diabetic class. It is primarily used to treat Type 2 diabetes. Type 2 diabetes is a common condition that causes the level of glucose (sugar) in the blood to become too high. It's a lifelong condition that can affect your everyday life. You may need to change your diet, take medicines, and have regular check-ups to lead a normal life.

EMPAGLIFLOZIN+METFORMIN is composed of two antidiabetic medicines, namely: Empagliflozin and Metformin. Empagliflozin is a type of medicine known as a sodium-glucose co-transporter-2 (SGLT2) inhibitor. It reduces blood sugar levels in people with diabetes. It does this by helping remove excess sugar from your body through your pee. Metformin belongs to the class of biguanides and manages blood sugar levels, particularly in obese patients. It lowers your blood sugar levels by improving the way your body handles insulin. Altogether, they lower blood glucose more effectively.

Take this medication by mouth with or without food as directed by your doctor, usually once daily in the morning. The dosage is based on your medical condition and response to treatment. Use this medication regularly to get the most benefit from it. To help you remember, take it at the same time each day. Tell your doctor if your condition does not improve or worsen (if your blood sugar is too high or too low). In some cases, you may experience certain common side effects, such as frequent urination, mild skin rash or itchy skin, feeling sick (nausea), being sick (vomiting) or diarrhea, stomach ache, and loss of appetite. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Before taking this medication, tell your doctor or pharmacist if you are allergic to Empagliflozin and Metformin; or have other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. EMPAGLIFLOZIN+METFORMIN should not be stopped even if you feel better, without consulting your doctor as sugar level keeps changing. If you stop taking EMPAGLIFLOZIN+METFORMIN abruptly, it may increase your sugar levels which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy), and nerve damage (neuropathy). EMPAGLIFLOZIN+METFORMIN should not be taken if you have type 1 diabetes mellitus, severe kidney, or liver disease. During pregnancy/lactation, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor.

Uses of Gibtulio Met 12.5mg/500mg Tablet

Type 2 Diabetes mellitus 

Medicinal Benefits of Gibtulio Met 12.5mg/500mg Tablet

EMPAGLIFLOZIN+METFORMIN is composed of two antidiabetic medicines, namely: Empagliflozin and Metformin. Empagliflozin is a type of medicine known as a sodium-glucose co-transporter-2 (SGLT2) inhibitor. It reduces blood sugar levels in people with diabetes. It does this by helping remove excess sugar from your body through your pee. Metformin belongs to the class of biguanides and manages blood sugar levels, particularly in obese patients. It lowers your blood sugar levels by improving the way your body handles insulin. Altogether, they lower blood glucose more effectively.

Directions for Use

Take this medication as directed by your doctor. The dosage is based on your medical condition and response to treatment. Use this medication regularly to get the most benefit from it. To help you remember, take it at the same time each day.

Side Effects of Gibtulio Met 12.5mg/500mg Tablet

• Thrush
• Pain or a burning feeling when you pee
• Mild skin rash or itchy skin
• Feeling sick (nausea)
• Being sick (vomiting) or diarrhea
• Stomach ache
• Loss of appetite
• A metallic taste in the mouth
• lactic acidosis

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

Before taking this medication, tell your doctor or pharmacist if you are allergic to Empagliflozin and Metformin; or have other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. EMPAGLIFLOZIN+METFORMIN should not be stopped even if you feel better, without consulting your doctor as sugar level keeps changing. If you stop taking EMPAGLIFLOZIN+METFORMIN abruptly, it may increase your sugar levels which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy), and nerve damage (neuropathy). EMPAGLIFLOZIN+METFORMIN should not be taken if you have type 1 diabetes mellitus, severe kidney, or liver disease. It's generally not recommended to take empagliflozin during pregnancy/breastfeeding. Discuss the risks and benefits with your doctor. EMPAGLIFLOZIN+METFORMIN is only for adults (from 18 years). It is not recommended for anyone aged 85 years or older.

Drug Interactions

Drug-Drug Interaction:

EMPAGLIFLOZIN+METFORMIN may interact with Steroid tablets (e.g. prednisolone), diuretic medications (e.g. furosemide), chest pain medications (e.g. nitrates), muscle relaxants (baclofen), medicines that cause low blood sugar (e.g. insulin, gliclazide). And also, inform all your medical conditions, and ongoing therapies to your doctor before prescribing this medication. By considering these, your doctor may check the drug interactions before prescribing this medication.

Drug-Disease Interaction:

EMPAGLIFLOZIN+METFORMIN is contraindicated in patients with uncontrolled diabetes, liver or kidney problems, severe infection, severe problems with circulation or breathing difficulties being treated for heart failure, or recently had a heart attack.

Safety Advice

ALCOHOL

It is advised to avoid alcohol intake since it may worsen the side effects like lactic acidosis and increase the risk of developing low blood sugar levels.

PREGNANCY

Empagliflozin in EMPAGLIFLOZIN+METFORMIN is not generally recommended in pregnancy. It is not clear whether empagliflozin can harm an unborn baby. Your doctor may suggest other medications to control your blood sugar levels. Please consult your doctor before starting EMPAGLIFLOZIN+METFORMIN if you are pregnant or planning to conceive.

BREAST FEEDING

EMPAGLIFLOZIN+METFORMIN may be unsafe to use during breastfeeding since it is excreted into breast milk. Please seek medical advice for further information.

DRIVING

You’re driving may be affected if your blood sugar levels are too high or too low. Do not drive or operate machinery if you also experience blurred vision, dizziness, or drowsiness due to extremely low or high blood sugar.

LIVER

Let your doctor know if you have any history of liver diseases or hepatic impairment when prescribed EMPAGLIFLOZIN+METFORMIN.

KIDNEY

EMPAGLIFLOZIN+METFORMIN is contraindicated in patients with severe renal impairment/kidney diseases. Let your doctor know if you have any history of kidney diseases when you are prescribed EMPAGLIFLOZIN+METFORMIN.